2 completed, 2 terminated. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 2 |
| Phase 2 | 1 | Completed 1 |
Follow Cutaneous Lupus: new trials by email Literature Review of Cutaneous Lupus trials Research Report on Cutaneous Lupus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus Tofacitinib - Cutaneous Lupus | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 7 | 2022-09-30 | 2025-08-22 |
| Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus Tofacitinib - Cutaneous Lupus, Systemic Lupus Erythematosus | Phase 1 / Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 13 | 2017-08-23 | 2026-03-03 |
| Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus AMG 557, AMG 557 Placebo - Cutaneous Lupus, Lupus | Phase 1 | Terminated | Amgen | 1 | 2011-10-01 | 2014-01-10 |
| Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus AMG811, AMG811 Placebo - Cutaneous Lupus, Discoid Lupus | Phase 1 | Terminated | Amgen | 16 | 2010-08-01 | 2014-09-16 |
Lupus Erythematosus, Systemic (2) · Lupus Erythematosus, Discoid (1)
Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Skin and Connective Tissue Diseases (2) · Lupus Erythematosus, Cutaneous (1) · Skin Diseases (1)
tofacitinib (2) · AMG 557 (1)
Amgen (2) · Children's Hospital Medical Center, Cincinnati (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (4) · Australia (1) · Canada (1)
Hermine Brunner, MD (1) · Joanne M Kahlenberg, M.D., Ph.D. (1)